KLOW 99% 80MG hot

  Product Detail  

1. Indications:

   Samaglutide Product Introduction

   I. Basic Information
   Name: KLOW
   CAS No.: 2381089-83-2
   Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
   Molecular Weight: 4113.58 Da
   Structure: Long-acting GLP-1 receptor agonist, fatty acid modified, half-life approximately 7 days

   Appearance: White lyophilized powder
   Purity: ≥99% (HPLC-MS)

   II. Mechanism of Action (GLP-1 monoreceptor agonist)
   

   • KLOW Peptide is a premium, research-grade synthetic multi-peptide blend, formulated with four well-characterized bioactive peptides, and KPV (Lys-Pro-Val Tripeptide) in a scientifically optimized ratio. It is commercially supplied as a sterile, lyophilized powder in sealed vials, designed exclusively for in vitro laboratory research and preclinical experimental applications. As a synergistic 4-in-1 peptide formulation, KLOW Peptide integrates the complementary biological pathways of each individual peptide component, enabling comprehensive multi-target research in the fields of tissue regeneration, inflammatory response regulation, cell signaling, and wound healing mechanisms. Compared with purchasing individual peptides separately, this pre-blended formulation simplifies the experimental operation process, reduces the cost of scientific research procurement, and ensures batch-to-batch consistency in experimental studies.

   • 
     

   III. Core Efficacy
   Weight Loss 
   STEP 1: Average weight loss over 68 weeks 14–15% (approximately 15.5 kg)

   Over 80% fat loss, muscle preservation

   Blood sugar reduction 

   Type 2 diabetes: HbA1c reduction of 1.5–2.0%

   Improved metabolism

   Benefits include lowering blood pressure, improving blood lipids, and reducing fatty liver

   Cardiovascular benefits

   SELECT trial: 20% reduction in MACE risk in overweight/obese individuals

   We’re currently running a popular 10% off promotion